191 related articles for article (PubMed ID: 9680368)
1. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells.
Romano MF; Lamberti A; Tassone P; Alfinito F; Costantini S; Chiurazzi F; Defrance T; Bonelli P; Tuccillo F; Turco MC; Venuta S
Blood; 1998 Aug; 92(3):990-5. PubMed ID: 9680368
[TBL] [Abstract][Full Text] [Related]
2. CD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-kappaB/Rel transcription factors on chemotherapy-induced apoptosis.
Romano MF; Lamberti A; Turco MC; Venuta S
Leuk Lymphoma; 2000 Jan; 36(3-4):255-62. PubMed ID: 10674897
[TBL] [Abstract][Full Text] [Related]
3. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
4. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
5. DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.
Horie R; Watanabe M; Okamura T; Taira M; Shoda M; Motoji T; Utsunomiya A; Watanabe T; Higashihara M; Umezawa K
Leukemia; 2006 May; 20(5):800-6. PubMed ID: 16525497
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
[TBL] [Abstract][Full Text] [Related]
7. The ability of CD40L, but not lipopolysaccharide, to initiate immunoglobulin switching to immunoglobulin G1 is explained by differential induction of NF-kappaB/Rel proteins.
Lin SC; Wortis HH; Stavnezer J
Mol Cell Biol; 1998 Sep; 18(9):5523-32. PubMed ID: 9710636
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
[TBL] [Abstract][Full Text] [Related]
9. The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.
Hewamana S; Lin TT; Jenkins C; Burnett AK; Jordan CT; Fegan C; Brennan P; Rowntree C; Pepper C
Clin Cancer Res; 2008 Dec; 14(24):8102-11. PubMed ID: 19088025
[TBL] [Abstract][Full Text] [Related]
10. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
Mineva ND; Rothstein TL; Meyers JA; Lerner A; Sonenshein GE
J Biol Chem; 2007 Jun; 282(24):17475-85. PubMed ID: 17446175
[TBL] [Abstract][Full Text] [Related]
11. The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target.
Hewamana S; Alghazal S; Lin TT; Clement M; Jenkins C; Guzman ML; Jordan CT; Neelakantan S; Crooks PA; Burnett AK; Pratt G; Fegan C; Rowntree C; Brennan P; Pepper C
Blood; 2008 May; 111(9):4681-9. PubMed ID: 18227347
[TBL] [Abstract][Full Text] [Related]
12. Activation of NF-kappaB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cgamma1 promoter.
Lin SC; Stavnezer J
Mol Cell Biol; 1996 Sep; 16(9):4591-603. PubMed ID: 8756615
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
König A; Menzel T; Lynen S; Wrazel L; Rosén A; Al-Katib A; Raveche E; Gabrilove JL
Leukemia; 1997 Feb; 11(2):258-65. PubMed ID: 9009090
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications.
Arima N; Matsushita K; Obata H; Ohtsubo H; Fujiwara H; Arimura K; Kukita T; Suruga Y; Wakamatsu S; Hidaka S; Tei C
Exp Hematol; 1999 Jul; 27(7):1168-75. PubMed ID: 10390192
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells.
Dietrich S; Krämer OH; Hahn E; Schäfer C; Giese T; Hess M; Tretter T; Rieger M; Hüllein J; Zenz T; Ho AD; Dreger P; Luft T
Clin Cancer Res; 2012 Jan; 18(2):417-31. PubMed ID: 22072733
[TBL] [Abstract][Full Text] [Related]
16. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Tromp JM; Geest CR; Breij EC; Elias JA; van Laar J; Luijks DM; Kater AP; Beaumont T; van Oers MH; Eldering E
Clin Cancer Res; 2012 Jan; 18(2):487-98. PubMed ID: 22128299
[TBL] [Abstract][Full Text] [Related]
17. 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells: p50 homodimer activation is not affected.
Ruby CE; Leid M; Kerkvliet NI
Mol Pharmacol; 2002 Sep; 62(3):722-8. PubMed ID: 12181450
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of the combination gemcitabine + fludarabine on freshly isolated chronic lymphocytic leukemia cells.
Tosi P; Pellacani A; Zinzani PL; Magagnoli M; Visani G; Tura S
Haematologica; 1999 Sep; 84(9):794-8. PubMed ID: 10477451
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia.
Bellosillo B; Villamor N; Colomer D; Pons G; Montserrat E; Gil J
Blood; 1999 Oct; 94(8):2836-43. PubMed ID: 10515887
[TBL] [Abstract][Full Text] [Related]
20. The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells.
Walsby E; Pearce L; Burnett AK; Fegan C; Pepper C
Oncotarget; 2012 May; 3(5):525-34. PubMed ID: 22619113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]